ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 285116 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 285116; 2) Community: the network communities that were significantly associated with the response to NSC 285116; 3) Molecule: the relationships between components within communities and NSC 285116; 4) MDR: the compounds that were significantly associated with the NSC 285116.

NSC Compound Enrichment Correlation
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.0314734733353267 0.28582564
NSC 750743 (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0314734733353267 0.25713515
NSC 755423 Null 0.0314734733353267 0.26328489
NSC 756134 GSK1023156A 0.0314734733353267 0.18757527
NSC 756233 GW435821X 0.0314734733353267 0.21171891
NSC 75890 1,9-Pyrazoloanthrone 0.0314734733353267 0.081669073
NSC 743694 Null 0.0329129886465385 0.41804234
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.0329129886465387 0.41987636
NSC 329277 Null 0.0329129886465387 0.12930772
NSC 382054 1H-Benzotriazolium, 6-(2,4-diamino-6-ethyl-5-pyrimidinyl)- 1-hydroxy-2-phenyl-, hydroxide, inner salt 0.0329129886465387 0.34554462
Total:104  Current:76    [First] [Prev] [Next] [Last]